Clinical Trial Update: Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy of ticagrelor plus aspirin in mild non-cardioembolic ischemic stroke and TIA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Status: COMPLETED